Procainamide Hydrochloride — CAS 614-39-1

Procainamide Hydrochloride is a Class IA antiarrhythmic agent that blocks sodium channels in cardiac tissue, thereby reducing automaticity and prolonging the refractory period. It is used intravenously for the management of acute ventricular arrhythmias and atrial fibrillation. Mediocon Inc manufactures Procainamide Hydrochloride API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Treatment of life-threatening ventricular arrhythmias (VT, VF)
• Management of atrial fibrillation and atrial flutter (cardioversion)
• Treatment of WPW syndrome-associated tachyarrhythmias
• Suppression of premature ventricular contractions (PVCs)

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support